Table 1 Characteristics of the study population at enrolment, 1999–2013, (n = 9320; only selected migrant groups shown)
Characteristic at enrolment | Non-Migrants | Western Europe | Central Europe | Eastern Europe | Sub-Sahara Africa | South-East Asia |
|---|---|---|---|---|---|---|
Total number of patients | 7,427 | 307 | 463 | 280 | 1,167 | 263 |
Median Age (in years); (interquartile range) | 38 (31–45) | 37 (31–44) | 34 (29–42) | 31 (26–37) | 33 (28–39) | 33 (28–39) |
Sex | ||||||
Female; n (%) | 890 (12) | 33 (11) | 85 (18) | 110 (39) | 708 (61) | 127 (48) |
Male; n (%) | 6537 (88) | 274 (89) | 378 (82) | 170 (61) | 459 (39) | 136 (52) |
Transmission Group; n (%) | ||||||
MSM | 4,724 (64) | 187 (61) | 209 (45) | 62 (22) | 22 (2) | 72 (27) |
IDU | 610 (8) | 29 (9) | 41 (9) | 76 (27) | 7 (0.60) | 6 (2) |
Hetero | 1,348 (18) | 50 (16) | 151 (33) | 94 (34) | 3 (0.26) | 31 (12) |
High prevalence country (HPC)a | -- | 7 (2) | 5 (1) | 6 (2) | 1,135 (97) | 133 (51) |
Unknown | 745 (10) | 34 (11) | 57 (12) | 42 (15) | -- | 21 (8) |
Patients with AIDS; n (%) | 1,086 (15) | 43 (14) | 66 (14) | 18 (6) | 184 (16) | 72 (27) |
Median CD4-count (cells/μl); (interquartile range) | 340; (162–520) | 305; (122–521) | 310; (140–467) | 398; (235–561) | 253; (120–410) | 198; (64–369) |